CSIS WARRANT SERIES I vs Prodia Diagnostic Line Tbk — how do they compare? CSIS WARRANT SERIES I trades at Rp86 (market cap 4.6B, 1.3K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 12.32M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 102.3× CSIS WARRANT SERIES I's market cap, and Prodia Diagnostic Line Tbk is more actively traded (12.32M versus 1.3K). Which is the better fit depends on your goals.
| CSIS-W | PRDL | |
|---|---|---|
Market Cap | 4.6B | 470.58B |
Volume | 1.3K | 12.32M |
Lot | 13 | 123.16K |
Turnover | 111.3K | 3.24B |
Average Price | 85.62 | 263.24 |
Value | 111.3K | 3.24B |
Indicative Equilibrium Price | — | 272 |
Indicative Equilibrium Volume | — | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →